nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2A6—Ifosfamide—testicular cancer	0.139	0.203	CbGbCtD
Eletriptan—PTGS1—Ifosfamide—testicular cancer	0.119	0.174	CbGbCtD
Eletriptan—CYP2C19—Ifosfamide—testicular cancer	0.0574	0.0841	CbGbCtD
Eletriptan—PTGS1—Etoposide—testicular cancer	0.0567	0.083	CbGbCtD
Eletriptan—CYP2C9—Ifosfamide—testicular cancer	0.0477	0.0699	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—testicular cancer	0.0392	0.0575	CbGbCtD
Eletriptan—CYP3A4—Ifosfamide—testicular cancer	0.0277	0.0407	CbGbCtD
Eletriptan—ABCB1—Vinblastine—testicular cancer	0.0246	0.036	CbGbCtD
Eletriptan—CYP2C9—Cisplatin—testicular cancer	0.0232	0.034	CbGbCtD
Eletriptan—CYP2D6—Vinblastine—testicular cancer	0.0231	0.0339	CbGbCtD
Eletriptan—ABCB1—Cisplatin—testicular cancer	0.0225	0.033	CbGbCtD
Eletriptan—ABCB1—Etoposide—testicular cancer	0.0221	0.0324	CbGbCtD
Eletriptan—HTR7—vas deferens—testicular cancer	0.0207	0.477	CbGeAlD
Eletriptan—ABCB1—Doxorubicin—testicular cancer	0.0151	0.0221	CbGbCtD
Eletriptan—CYP3A4—Vinblastine—testicular cancer	0.0147	0.0216	CbGbCtD
Eletriptan—ABCB1—Methotrexate—testicular cancer	0.0146	0.0214	CbGbCtD
Eletriptan—CYP2D6—Doxorubicin—testicular cancer	0.0142	0.0208	CbGbCtD
Eletriptan—CYP3A4—Etoposide—testicular cancer	0.0133	0.0194	CbGbCtD
Eletriptan—CYP3A4—Doxorubicin—testicular cancer	0.00904	0.0133	CbGbCtD
Eletriptan—HTR7—vein—testicular cancer	0.00879	0.203	CbGeAlD
Eletriptan—HTR1E—female gonad—testicular cancer	0.00252	0.058	CbGeAlD
Eletriptan—CYP2A6—seminal vesicle—testicular cancer	0.00237	0.0547	CbGeAlD
Eletriptan—HTR7—gonad—testicular cancer	0.00113	0.026	CbGeAlD
Eletriptan—PTGS1—seminal vesicle—testicular cancer	0.00108	0.0249	CbGeAlD
Eletriptan—HTR7—testis—testicular cancer	0.000814	0.0188	CbGeAlD
Eletriptan—HTR2B—lymph node—testicular cancer	0.000689	0.0159	CbGeAlD
Eletriptan—ABCB1—embryo—testicular cancer	0.00068	0.0157	CbGeAlD
Eletriptan—ABCB1—seminal vesicle—testicular cancer	0.000638	0.0147	CbGeAlD
Eletriptan—PTGS1—female gonad—testicular cancer	0.000634	0.0146	CbGeAlD
Eletriptan—PTGS1—testis—testicular cancer	0.000562	0.013	CbGeAlD
Eletriptan—CYP2D6—female gonad—testicular cancer	0.000521	0.012	CbGeAlD
Eletriptan—CYP2D6—testis—testicular cancer	0.000462	0.0107	CbGeAlD
Eletriptan—ABCB1—gonad—testicular cancer	0.000461	0.0106	CbGeAlD
Eletriptan—PTGS1—lymph node—testicular cancer	0.000408	0.0094	CbGeAlD
Eletriptan—ABCB1—female gonad—testicular cancer	0.000375	0.00864	CbGeAlD
Eletriptan—ABCB1—testis—testicular cancer	0.000333	0.00767	CbGeAlD
Eletriptan—ABCB1—lymph node—testicular cancer	0.000241	0.00556	CbGeAlD
Eletriptan—Decreased appetite—Etoposide—testicular cancer	0.00022	0.000804	CcSEcCtD
Eletriptan—Diarrhoea—Ifosfamide—testicular cancer	0.00022	0.000801	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000219	0.000798	CcSEcCtD
Eletriptan—Body temperature increased—Cisplatin—testicular cancer	0.000219	0.000798	CcSEcCtD
Eletriptan—Fatigue—Etoposide—testicular cancer	0.000219	0.000797	CcSEcCtD
Eletriptan—Neuropathy peripheral—Epirubicin—testicular cancer	0.000218	0.000797	CcSEcCtD
Eletriptan—Stomatitis—Epirubicin—testicular cancer	0.000217	0.000792	CcSEcCtD
Eletriptan—Pain—Etoposide—testicular cancer	0.000217	0.000791	CcSEcCtD
Eletriptan—Constipation—Etoposide—testicular cancer	0.000217	0.000791	CcSEcCtD
Eletriptan—Conjunctivitis—Epirubicin—testicular cancer	0.000217	0.00079	CcSEcCtD
Eletriptan—Sweating—Epirubicin—testicular cancer	0.000214	0.000779	CcSEcCtD
Eletriptan—Pollakiuria—Doxorubicin—testicular cancer	0.000214	0.000779	CcSEcCtD
Eletriptan—Dizziness—Ifosfamide—testicular cancer	0.000212	0.000774	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—testicular cancer	0.000212	0.000774	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—testicular cancer	0.000211	0.00077	CcSEcCtD
Eletriptan—Weight increased—Doxorubicin—testicular cancer	0.00021	0.000767	CcSEcCtD
Eletriptan—Epistaxis—Epirubicin—testicular cancer	0.00021	0.000766	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—testicular cancer	0.000209	0.000764	CcSEcCtD
Eletriptan—Weight decreased—Doxorubicin—testicular cancer	0.000209	0.000763	CcSEcCtD
Eletriptan—Sinusitis—Epirubicin—testicular cancer	0.000209	0.000762	CcSEcCtD
Eletriptan—Feeling abnormal—Etoposide—testicular cancer	0.000209	0.000762	CcSEcCtD
Eletriptan—Hyperglycaemia—Doxorubicin—testicular cancer	0.000209	0.000761	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—testicular cancer	0.000208	0.000759	CcSEcCtD
Eletriptan—Gastrointestinal pain—Etoposide—testicular cancer	0.000207	0.000756	CcSEcCtD
Eletriptan—Drowsiness—Doxorubicin—testicular cancer	0.000206	0.000752	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—testicular cancer	0.000206	0.000751	CcSEcCtD
Eletriptan—Vomiting—Ifosfamide—testicular cancer	0.000204	0.000744	CcSEcCtD
Eletriptan—Hypersensitivity—Cisplatin—testicular cancer	0.000204	0.000744	CcSEcCtD
Eletriptan—Bradycardia—Epirubicin—testicular cancer	0.000204	0.000743	CcSEcCtD
Eletriptan—Rash—Ifosfamide—testicular cancer	0.000202	0.000738	CcSEcCtD
Eletriptan—Dermatitis—Ifosfamide—testicular cancer	0.000202	0.000737	CcSEcCtD
Eletriptan—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000202	0.000737	CcSEcCtD
Eletriptan—Urticaria—Etoposide—testicular cancer	0.000201	0.000735	CcSEcCtD
Eletriptan—Stomatitis—Doxorubicin—testicular cancer	0.000201	0.000733	CcSEcCtD
Eletriptan—Rhinitis—Epirubicin—testicular cancer	0.0002	0.000731	CcSEcCtD
Eletriptan—Abdominal pain—Etoposide—testicular cancer	0.0002	0.000731	CcSEcCtD
Eletriptan—Body temperature increased—Etoposide—testicular cancer	0.0002	0.000731	CcSEcCtD
Eletriptan—Conjunctivitis—Doxorubicin—testicular cancer	0.0002	0.000731	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—testicular cancer	0.000199	0.000727	CcSEcCtD
Eletriptan—Hypoaesthesia—Epirubicin—testicular cancer	0.000199	0.000726	CcSEcCtD
Eletriptan—Asthenia—Cisplatin—testicular cancer	0.000199	0.000724	CcSEcCtD
Eletriptan—Pharyngitis—Epirubicin—testicular cancer	0.000198	0.000724	CcSEcCtD
Eletriptan—Sweating—Doxorubicin—testicular cancer	0.000198	0.000721	CcSEcCtD
Eletriptan—Urinary tract disorder—Epirubicin—testicular cancer	0.000197	0.00072	CcSEcCtD
Eletriptan—Oedema peripheral—Epirubicin—testicular cancer	0.000197	0.000719	CcSEcCtD
Eletriptan—Urethral disorder—Epirubicin—testicular cancer	0.000196	0.000715	CcSEcCtD
Eletriptan—Epistaxis—Doxorubicin—testicular cancer	0.000194	0.000709	CcSEcCtD
Eletriptan—Sinusitis—Doxorubicin—testicular cancer	0.000193	0.000705	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—testicular cancer	0.000193	0.000704	CcSEcCtD
Eletriptan—Visual impairment—Epirubicin—testicular cancer	0.000193	0.000703	CcSEcCtD
Eletriptan—Chills—Methotrexate—testicular cancer	0.000192	0.000699	CcSEcCtD
Eletriptan—Nausea—Ifosfamide—testicular cancer	0.000191	0.000695	CcSEcCtD
Eletriptan—Diarrhoea—Cisplatin—testicular cancer	0.000189	0.000691	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—testicular cancer	0.000189	0.000689	CcSEcCtD
Eletriptan—Bradycardia—Doxorubicin—testicular cancer	0.000188	0.000687	CcSEcCtD
Eletriptan—Hypersensitivity—Etoposide—testicular cancer	0.000187	0.000681	CcSEcCtD
Eletriptan—Tinnitus—Epirubicin—testicular cancer	0.000186	0.00068	CcSEcCtD
Eletriptan—Flushing—Epirubicin—testicular cancer	0.000186	0.000677	CcSEcCtD
Eletriptan—Rhinitis—Doxorubicin—testicular cancer	0.000186	0.000677	CcSEcCtD
Eletriptan—Hypoaesthesia—Doxorubicin—testicular cancer	0.000184	0.000672	CcSEcCtD
Eletriptan—Pharyngitis—Doxorubicin—testicular cancer	0.000184	0.00067	CcSEcCtD
Eletriptan—Urinary tract disorder—Doxorubicin—testicular cancer	0.000183	0.000667	CcSEcCtD
Eletriptan—Oedema peripheral—Doxorubicin—testicular cancer	0.000182	0.000665	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—testicular cancer	0.000182	0.000665	CcSEcCtD
Eletriptan—Asthenia—Etoposide—testicular cancer	0.000182	0.000663	CcSEcCtD
Eletriptan—Urethral disorder—Doxorubicin—testicular cancer	0.000181	0.000662	CcSEcCtD
Eletriptan—Immune system disorder—Epirubicin—testicular cancer	0.000181	0.000659	CcSEcCtD
Eletriptan—Back pain—Methotrexate—testicular cancer	0.00018	0.000656	CcSEcCtD
Eletriptan—Chills—Epirubicin—testicular cancer	0.000179	0.000655	CcSEcCtD
Eletriptan—Pruritus—Etoposide—testicular cancer	0.000179	0.000654	CcSEcCtD
Eletriptan—Arrhythmia—Epirubicin—testicular cancer	0.000179	0.000652	CcSEcCtD
Eletriptan—Visual impairment—Doxorubicin—testicular cancer	0.000178	0.00065	CcSEcCtD
Eletriptan—Alopecia—Epirubicin—testicular cancer	0.000177	0.000645	CcSEcCtD
Eletriptan—Vomiting—Cisplatin—testicular cancer	0.000176	0.000642	CcSEcCtD
Eletriptan—Rash—Cisplatin—testicular cancer	0.000174	0.000636	CcSEcCtD
Eletriptan—Dermatitis—Cisplatin—testicular cancer	0.000174	0.000636	CcSEcCtD
Eletriptan—Diarrhoea—Etoposide—testicular cancer	0.000173	0.000633	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—testicular cancer	0.000173	0.00063	CcSEcCtD
Eletriptan—Tinnitus—Doxorubicin—testicular cancer	0.000173	0.000629	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—testicular cancer	0.000172	0.000627	CcSEcCtD
Eletriptan—Flushing—Doxorubicin—testicular cancer	0.000172	0.000626	CcSEcCtD
Eletriptan—Flatulence—Epirubicin—testicular cancer	0.000172	0.000626	CcSEcCtD
Eletriptan—Tension—Epirubicin—testicular cancer	0.000171	0.000623	CcSEcCtD
Eletriptan—Dysgeusia—Epirubicin—testicular cancer	0.00017	0.000622	CcSEcCtD
Eletriptan—Nervousness—Epirubicin—testicular cancer	0.000169	0.000617	CcSEcCtD
Eletriptan—Back pain—Epirubicin—testicular cancer	0.000168	0.000614	CcSEcCtD
Eletriptan—Malaise—Methotrexate—testicular cancer	0.000168	0.000612	CcSEcCtD
Eletriptan—Dizziness—Etoposide—testicular cancer	0.000168	0.000611	CcSEcCtD
Eletriptan—Muscle spasms—Epirubicin—testicular cancer	0.000167	0.000611	CcSEcCtD
Eletriptan—Immune system disorder—Doxorubicin—testicular cancer	0.000167	0.00061	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—testicular cancer	0.000167	0.00061	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—testicular cancer	0.000167	0.000607	CcSEcCtD
Eletriptan—Chills—Doxorubicin—testicular cancer	0.000166	0.000606	CcSEcCtD
Eletriptan—Arrhythmia—Doxorubicin—testicular cancer	0.000165	0.000603	CcSEcCtD
Eletriptan—Nausea—Cisplatin—testicular cancer	0.000164	0.000599	CcSEcCtD
Eletriptan—Alopecia—Doxorubicin—testicular cancer	0.000164	0.000596	CcSEcCtD
Eletriptan—Cough—Methotrexate—testicular cancer	0.000162	0.000592	CcSEcCtD
Eletriptan—Ill-defined disorder—Epirubicin—testicular cancer	0.000162	0.000589	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—testicular cancer	0.000161	0.000588	CcSEcCtD
Eletriptan—Vomiting—Etoposide—testicular cancer	0.000161	0.000588	CcSEcCtD
Eletriptan—Anaemia—Epirubicin—testicular cancer	0.000161	0.000587	CcSEcCtD
Eletriptan—Agitation—Epirubicin—testicular cancer	0.00016	0.000584	CcSEcCtD
Eletriptan—Rash—Etoposide—testicular cancer	0.00016	0.000583	CcSEcCtD
Eletriptan—Dermatitis—Etoposide—testicular cancer	0.00016	0.000582	CcSEcCtD
Eletriptan—Headache—Etoposide—testicular cancer	0.000159	0.000579	CcSEcCtD
Eletriptan—Flatulence—Doxorubicin—testicular cancer	0.000159	0.000579	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—testicular cancer	0.000158	0.000578	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—testicular cancer	0.000158	0.000578	CcSEcCtD
Eletriptan—Tension—Doxorubicin—testicular cancer	0.000158	0.000577	CcSEcCtD
Eletriptan—Dysgeusia—Doxorubicin—testicular cancer	0.000158	0.000575	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000157	0.000574	CcSEcCtD
Eletriptan—Malaise—Epirubicin—testicular cancer	0.000157	0.000573	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—testicular cancer	0.000156	0.000571	CcSEcCtD
Eletriptan—Nervousness—Doxorubicin—testicular cancer	0.000156	0.000571	CcSEcCtD
Eletriptan—Vertigo—Epirubicin—testicular cancer	0.000156	0.000571	CcSEcCtD
Eletriptan—Syncope—Epirubicin—testicular cancer	0.000156	0.000569	CcSEcCtD
Eletriptan—Leukopenia—Epirubicin—testicular cancer	0.000156	0.000568	CcSEcCtD
Eletriptan—Back pain—Doxorubicin—testicular cancer	0.000156	0.000568	CcSEcCtD
Eletriptan—Muscle spasms—Doxorubicin—testicular cancer	0.000155	0.000565	CcSEcCtD
Eletriptan—Palpitations—Epirubicin—testicular cancer	0.000154	0.000561	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—testicular cancer	0.000153	0.000558	CcSEcCtD
Eletriptan—Loss of consciousness—Epirubicin—testicular cancer	0.000153	0.000558	CcSEcCtD
Eletriptan—Cough—Epirubicin—testicular cancer	0.000152	0.000554	CcSEcCtD
Eletriptan—Convulsion—Epirubicin—testicular cancer	0.000151	0.00055	CcSEcCtD
Eletriptan—Nausea—Etoposide—testicular cancer	0.000151	0.000549	CcSEcCtD
Eletriptan—Hypertension—Epirubicin—testicular cancer	0.00015	0.000548	CcSEcCtD
Eletriptan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000149	0.000545	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—testicular cancer	0.000149	0.000543	CcSEcCtD
Eletriptan—Anaemia—Doxorubicin—testicular cancer	0.000149	0.000543	CcSEcCtD
Eletriptan—Arthralgia—Epirubicin—testicular cancer	0.000148	0.000541	CcSEcCtD
Eletriptan—Myalgia—Epirubicin—testicular cancer	0.000148	0.000541	CcSEcCtD
Eletriptan—Agitation—Doxorubicin—testicular cancer	0.000148	0.00054	CcSEcCtD
Eletriptan—Anxiety—Epirubicin—testicular cancer	0.000148	0.000539	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—testicular cancer	0.000147	0.000538	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000147	0.000537	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—testicular cancer	0.000147	0.000535	CcSEcCtD
Eletriptan—Discomfort—Epirubicin—testicular cancer	0.000146	0.000534	CcSEcCtD
Eletriptan—Malaise—Doxorubicin—testicular cancer	0.000145	0.00053	CcSEcCtD
Eletriptan—Dry mouth—Epirubicin—testicular cancer	0.000145	0.000529	CcSEcCtD
Eletriptan—Vertigo—Doxorubicin—testicular cancer	0.000145	0.000528	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—testicular cancer	0.000145	0.000528	CcSEcCtD
Eletriptan—Syncope—Doxorubicin—testicular cancer	0.000144	0.000527	CcSEcCtD
Eletriptan—Leukopenia—Doxorubicin—testicular cancer	0.000144	0.000526	CcSEcCtD
Eletriptan—Confusional state—Epirubicin—testicular cancer	0.000143	0.000523	CcSEcCtD
Eletriptan—Palpitations—Doxorubicin—testicular cancer	0.000142	0.000519	CcSEcCtD
Eletriptan—Oedema—Epirubicin—testicular cancer	0.000142	0.000518	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—testicular cancer	0.000142	0.000517	CcSEcCtD
Eletriptan—Loss of consciousness—Doxorubicin—testicular cancer	0.000142	0.000516	CcSEcCtD
Eletriptan—Cough—Doxorubicin—testicular cancer	0.000141	0.000513	CcSEcCtD
Eletriptan—Shock—Epirubicin—testicular cancer	0.00014	0.00051	CcSEcCtD
Eletriptan—Convulsion—Doxorubicin—testicular cancer	0.00014	0.000509	CcSEcCtD
Eletriptan—Nervous system disorder—Epirubicin—testicular cancer	0.000139	0.000508	CcSEcCtD
Eletriptan—Hypertension—Doxorubicin—testicular cancer	0.000139	0.000507	CcSEcCtD
Eletriptan—Tachycardia—Epirubicin—testicular cancer	0.000139	0.000506	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000138	0.000505	CcSEcCtD
Eletriptan—Skin disorder—Epirubicin—testicular cancer	0.000138	0.000503	CcSEcCtD
Eletriptan—Hyperhidrosis—Epirubicin—testicular cancer	0.000137	0.000501	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—testicular cancer	0.000137	0.000501	CcSEcCtD
Eletriptan—Myalgia—Doxorubicin—testicular cancer	0.000137	0.0005	CcSEcCtD
Eletriptan—Arthralgia—Doxorubicin—testicular cancer	0.000137	0.0005	CcSEcCtD
Eletriptan—Anxiety—Doxorubicin—testicular cancer	0.000137	0.000499	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—testicular cancer	0.000136	0.000497	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000136	0.000497	CcSEcCtD
Eletriptan—Discomfort—Doxorubicin—testicular cancer	0.000135	0.000494	CcSEcCtD
Eletriptan—Anorexia—Epirubicin—testicular cancer	0.000135	0.000494	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—testicular cancer	0.000135	0.000494	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—testicular cancer	0.000135	0.000492	CcSEcCtD
Eletriptan—Dry mouth—Doxorubicin—testicular cancer	0.000134	0.000489	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—testicular cancer	0.000134	0.000487	CcSEcCtD
Eletriptan—Hypotension—Epirubicin—testicular cancer	0.000133	0.000484	CcSEcCtD
Eletriptan—Confusional state—Doxorubicin—testicular cancer	0.000133	0.000484	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—testicular cancer	0.000132	0.000481	CcSEcCtD
Eletriptan—Oedema—Doxorubicin—testicular cancer	0.000131	0.00048	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000131	0.000478	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—testicular cancer	0.000131	0.000477	CcSEcCtD
Eletriptan—Pain—Methotrexate—testicular cancer	0.00013	0.000474	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000129	0.000472	CcSEcCtD
Eletriptan—Shock—Doxorubicin—testicular cancer	0.000129	0.000472	CcSEcCtD
Eletriptan—Nervous system disorder—Doxorubicin—testicular cancer	0.000129	0.00047	CcSEcCtD
Eletriptan—Insomnia—Epirubicin—testicular cancer	0.000129	0.000469	CcSEcCtD
Eletriptan—Tachycardia—Doxorubicin—testicular cancer	0.000128	0.000468	CcSEcCtD
Eletriptan—Skin disorder—Doxorubicin—testicular cancer	0.000128	0.000466	CcSEcCtD
Eletriptan—Paraesthesia—Epirubicin—testicular cancer	0.000128	0.000465	CcSEcCtD
Eletriptan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000127	0.000464	CcSEcCtD
Eletriptan—Dyspnoea—Epirubicin—testicular cancer	0.000127	0.000462	CcSEcCtD
Eletriptan—Somnolence—Epirubicin—testicular cancer	0.000126	0.000461	CcSEcCtD
Eletriptan—Anorexia—Doxorubicin—testicular cancer	0.000125	0.000457	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—testicular cancer	0.000125	0.000456	CcSEcCtD
Eletriptan—Dyspepsia—Epirubicin—testicular cancer	0.000125	0.000456	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—testicular cancer	0.000124	0.000453	CcSEcCtD
Eletriptan—Decreased appetite—Epirubicin—testicular cancer	0.000124	0.000451	CcSEcCtD
Eletriptan—Hypotension—Doxorubicin—testicular cancer	0.000123	0.000448	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000123	0.000447	CcSEcCtD
Eletriptan—Fatigue—Epirubicin—testicular cancer	0.000122	0.000447	CcSEcCtD
Eletriptan—Pain—Epirubicin—testicular cancer	0.000122	0.000443	CcSEcCtD
Eletriptan—Constipation—Epirubicin—testicular cancer	0.000122	0.000443	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—testicular cancer	0.000121	0.00044	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—testicular cancer	0.00012	0.000438	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—testicular cancer	0.00012	0.000438	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00012	0.000437	CcSEcCtD
Eletriptan—Insomnia—Doxorubicin—testicular cancer	0.000119	0.000434	CcSEcCtD
Eletriptan—Paraesthesia—Doxorubicin—testicular cancer	0.000118	0.000431	CcSEcCtD
Eletriptan—Dyspnoea—Doxorubicin—testicular cancer	0.000117	0.000428	CcSEcCtD
Eletriptan—Feeling abnormal—Epirubicin—testicular cancer	0.000117	0.000427	CcSEcCtD
Eletriptan—Somnolence—Doxorubicin—testicular cancer	0.000117	0.000426	CcSEcCtD
Eletriptan—Gastrointestinal pain—Epirubicin—testicular cancer	0.000116	0.000424	CcSEcCtD
Eletriptan—Dyspepsia—Doxorubicin—testicular cancer	0.000116	0.000422	CcSEcCtD
Eletriptan—Decreased appetite—Doxorubicin—testicular cancer	0.000114	0.000417	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000113	0.000414	CcSEcCtD
Eletriptan—Fatigue—Doxorubicin—testicular cancer	0.000113	0.000413	CcSEcCtD
Eletriptan—Urticaria—Epirubicin—testicular cancer	0.000113	0.000412	CcSEcCtD
Eletriptan—Pain—Doxorubicin—testicular cancer	0.000112	0.00041	CcSEcCtD
Eletriptan—Constipation—Doxorubicin—testicular cancer	0.000112	0.00041	CcSEcCtD
Eletriptan—Abdominal pain—Epirubicin—testicular cancer	0.000112	0.00041	CcSEcCtD
Eletriptan—Body temperature increased—Epirubicin—testicular cancer	0.000112	0.00041	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—testicular cancer	0.000112	0.000408	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—testicular cancer	0.000109	0.000397	CcSEcCtD
Eletriptan—Feeling abnormal—Doxorubicin—testicular cancer	0.000108	0.000395	CcSEcCtD
Eletriptan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000108	0.000392	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—testicular cancer	0.000107	0.000392	CcSEcCtD
Eletriptan—Hypersensitivity—Epirubicin—testicular cancer	0.000105	0.000382	CcSEcCtD
Eletriptan—Urticaria—Doxorubicin—testicular cancer	0.000104	0.000381	CcSEcCtD
Eletriptan—Abdominal pain—Doxorubicin—testicular cancer	0.000104	0.000379	CcSEcCtD
Eletriptan—Body temperature increased—Doxorubicin—testicular cancer	0.000104	0.000379	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—testicular cancer	0.000104	0.000379	CcSEcCtD
Eletriptan—Asthenia—Epirubicin—testicular cancer	0.000102	0.000372	CcSEcCtD
Eletriptan—Pruritus—Epirubicin—testicular cancer	0.000101	0.000367	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—testicular cancer	0.0001	0.000366	CcSEcCtD
Eletriptan—Diarrhoea—Epirubicin—testicular cancer	9.72e-05	0.000355	CcSEcCtD
Eletriptan—Hypersensitivity—Doxorubicin—testicular cancer	9.69e-05	0.000353	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—testicular cancer	9.65e-05	0.000352	CcSEcCtD
Eletriptan—Rash—Methotrexate—testicular cancer	9.57e-05	0.000349	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—testicular cancer	9.56e-05	0.000349	CcSEcCtD
Eletriptan—Headache—Methotrexate—testicular cancer	9.51e-05	0.000347	CcSEcCtD
Eletriptan—Asthenia—Doxorubicin—testicular cancer	9.43e-05	0.000344	CcSEcCtD
Eletriptan—Dizziness—Epirubicin—testicular cancer	9.4e-05	0.000343	CcSEcCtD
Eletriptan—Pruritus—Doxorubicin—testicular cancer	9.3e-05	0.000339	CcSEcCtD
Eletriptan—Vomiting—Epirubicin—testicular cancer	9.03e-05	0.00033	CcSEcCtD
Eletriptan—Nausea—Methotrexate—testicular cancer	9.02e-05	0.000329	CcSEcCtD
Eletriptan—Diarrhoea—Doxorubicin—testicular cancer	9e-05	0.000328	CcSEcCtD
Eletriptan—Rash—Epirubicin—testicular cancer	8.96e-05	0.000327	CcSEcCtD
Eletriptan—Dermatitis—Epirubicin—testicular cancer	8.95e-05	0.000326	CcSEcCtD
Eletriptan—Headache—Epirubicin—testicular cancer	8.9e-05	0.000325	CcSEcCtD
Eletriptan—Dizziness—Doxorubicin—testicular cancer	8.69e-05	0.000317	CcSEcCtD
Eletriptan—Nausea—Epirubicin—testicular cancer	8.44e-05	0.000308	CcSEcCtD
Eletriptan—Vomiting—Doxorubicin—testicular cancer	8.36e-05	0.000305	CcSEcCtD
Eletriptan—Rash—Doxorubicin—testicular cancer	8.29e-05	0.000302	CcSEcCtD
Eletriptan—Dermatitis—Doxorubicin—testicular cancer	8.28e-05	0.000302	CcSEcCtD
Eletriptan—Headache—Doxorubicin—testicular cancer	8.24e-05	0.0003	CcSEcCtD
Eletriptan—Nausea—Doxorubicin—testicular cancer	7.81e-05	0.000285	CcSEcCtD
